Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimes

Clinical Microbiology and Infection

Volumn 8, Issue 9, 2002, Pages 598-603

  Loivukene K ^a,b   Maaroos, H I ^a   Kolk, H ^a   Kull, I ^a   Labotkin, K ^a   Mikelsaar, M ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b Department of Microbiology ^*  (Estonia)

Author keywords

Antibiotic susceptibility; Consumption of antibiotics; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG USE; ESTONIA; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PEPTIC ULCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STOMACH MUCOSA;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 0036750111     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00409.x     Document Type: Article

References (20)

1. Cover TL, Blaser MJ. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease and gastric cancer. ASM News 1995; 33: 1203-5.
2. Marshall BJ. Campylobacter pyloridis and gastritis. J Infect Dis 1986; 153: 650-8.
3. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 10: 984-91.
4. Van der Hulst RWM, van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GNJ. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998; 42: 166-9.
5. Megraud F, Lehn N, Lind T et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 Study. Antimicrob Agents Chemother 1999; 11: 2747-52.
6. Glupczynski Y. Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing. In: Megraud F, Lee A, eds. Helicobacter pylori-techniques for clinical diagnosis and basic research. London: W.B. Saunders Co.; 1996; 17-32.
7. Iovene MR, Romano M, Pilloni AP et al. Prevalence of antimicrobial resistance in 80 clinical isolates of Helicobacter pylori. Chemotherapy 1999; 45: 8-14.
8. Wang G, Taylor DE. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 1998; 8: 1952-8.
9. Garcia-Arata MI, Baquero F, de Rafael L et al. Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. Antimicrob Agents Chemother 1999; 2: 374-6.
10. McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994; 15: 478-83.
11. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11: 43-53.
12. Teare L, Peters T, Saverymuttu S, Owen R, Tiwari I. Antibiotic resistance in Helicobacter pylori. Lancet 1999; 353: 242.
13. Misiewicz CN, Tytgat CS, Goodwin CS et al. The Sydney system: a new classification of gastritis. Working Party Reports 1990: 1-10.
14. McLaren A. In vitro susceptibility testing of H. pylori. In: Clayton CL, Mobley HLT, eds. Helicobacter pylori protocols. Totowa: Humana Press Inc., 1997: 41-51.
15. DeCross A, Marshall BY, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth and agar dilution methods and their clinical revalence. J Clin Microbiol 1993; 4: 1971-4.
16. Seppälä H, Nissinen A, Järvinen H et al. Resistance to erythromycin in group a streptococci. N Engl J Med 1992; 326: 292-7.
17. Lerang F, Moum B, Ragnhildstveit E, Haug JB. Helicobacter pylori infection and metronidazole resistance. Gut 1995; 1: A343.
18. Lõivukene K, Kolk H, Maaroos HI et al. Metronidazole and Clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. Scand J Infect Dis 2000; 32: 59-62.
19. Smith MA, Edwards DI. Oxygen scavenging, NADH oxidase and metronidazole resistance in H. pylori. J Antimicrob Chemother 1997; 39: 347-53.
20. Bolmström A. Susceptibility testing of anaerobes with E-test. Clin Infect Dis 1993; 16 (Suppl. 4): S367-70.